Hello everyone, I have a different insurance provider for 2025 and their first order of business was to flag big-ticket treatments. Of course Actemra made it onto their list. They've agreed to cover its FDA-approved biosimilar, called Tyenne. As a GCA/ PMR sufferer currently stable (on weekly Actemra injections and 2mg pred) I am loathe to change anything. A bit of research was reassuring though, as the suggested replacement had to prove a 'nearly identical' efficacy and safety through US clinical trials. It's the 'nearly' that concerns me.
Any anecdotal experience to share? Thank you as always for any thoughts.